Clinical Trial Update: Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose interferon alpha for oral ulcers in Behçet's disease has completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease

Drugs mentioned

• Interferon alpha (low-dose) (Interferon alpha)

Snippet

Sponsor: Nobel Pharmaceuticals | Conditions: Behcet Syndrome, Behcet Disease | Phase 2 | Status: COMPLETED | Results posted: 2009-06-16